Hims & Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights

(NYSE:HIMS), NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed on behalf of all investors who purchased or otherwise acquired securities of Hims & Hers Health, Inc. (NYSE: HIMS) (“Hims & Hers” or the “Company”) securities between April 29, […]

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

(NasdaqGM:RCKT), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Rocket Pharmaceuticals between February 27, 2025 and May 26, 2025 and would like to discuss your legal rights, call

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

(NasdaqGM:IOVA), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Iovance To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Iovance between August 8, 2024 and May 8, 2025 and would like to discuss your legal rights, call Faruqi &

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals GlobeNewswire July 02, 2025 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Rocket

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics GlobeNewswire July 02, 2025 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Iovance To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Iovance between

Giga Metals Announces Proposed Debt Settlement

Giga Metals Announces Proposed Debt Settlement GlobeNewswire July 02, 2025 VANCOUVER, British Columbia, July 02, 2025 (GLOBE NEWSWIRE) — Giga Metals Corporation (TSX.V: GIGA, OTCQB: GIGGF) (the “Company“) announces that it's proposing to settle an aggregate of approximately $63,250 in debt through the issuance of common shares to be issued at a deemed price of

Hims & Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights

Hims & Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights GlobeNewswire July 02, 2025 NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed on behalf of all

ALR Miner launches $12 registration bonus to enable new investors to start smart cloud mining

ALR Miner launches $12 registration bonus to enable new investors to start smart cloud mining 7 years of safe operation, AI mining engine, zero risk for beginners GlobeNewswire July 02, 2025 London, UK, July 02, 2025 (GLOBE NEWSWIRE) — ALR Miner, a cloud mining platform which has more than 8 years of stable operation. Today,

VAYK Discloses More Insider Buying Approaching 15 Million

Vaycaychella, Inc. (OTC Pink: VAYK) (“VAYK”) confirmed today that a person who holds insider information has been purchasing VAYK shares on the open market since last November. In particular, the concerned person had further increased their holding in the last week of June 2025. “Per the voluntary disclosure provided by the said person, they had

Scroll to Top